Communication
RSC Advances
J. Lineberger, W. A. Schleif and E. A. Emini, Bioorg. Med. Chem.
Lett., 2001, 11, 3103.
freshly distilled before use and all reactions carried out under a
nitrogen atmosphere.
5 E. Rydzik and A. Szadowska, Acta Pol. Pharm., 1978, 35, 537.
6 E. Rydzik, A. Szadowska and A. Kaminska, Acta Pol. Pharm.,
1979, 36, 167.
7 S. Suzen and E. Buyukbingol, Farmaco, 2000, 55, 246.
8 A. M. Al-Obaid, H. I. El-Subbagh, A. I. Khodair and M. M.
A. Elmazar, Anti-Cancer Drugs, 1996, 7, 873.
9 M. Blanc, M. Cussac, A. Boucherle and G. Leclerc, Eur. J. Med.
Chem., 1992, 27, 839.
10 A.-S. S. Hamad Elgazwy, S. R. Atta-Allha and S. M. A. S. Keshk,
Monatsh. Chem., 2009, 140, 243.
11 A. A. El-Barbary, A. Z. Abou El-Ezz, A. M. Sharaf and C. Nielsen,
Phosphorus, Sulfur Silicon Relat. Elem., 2007, 182, 1621.
12 P. Dang and A. K. Madan, J. Chem. Inf. Comput. Sci., 1994, 34,
1162.
Spirodithiohydantoins 1a,b and benzimidazolium salts 6a,b
were prepared according to the procedure developed by our
group.22
General procedure for the preparation of benzimidazole-
thiones 5a,b from spirodithiohydantoins 1a,b
Spirodithiohydantoin 1a,b (1 mmol) and elemental sulphur (8.0
mmol) were mixed and heated at 80 uC for 5 h without solvent.
After 5 h, the residue was purified by flash chromatography using
EtOAc/hexanes to afford the corresponding benzimidazole-thiones
5a,b.
General procedure for the preparation of benzimidazole-
thiones 5a,b from benzimidazolium salts 6a,b
13 S. Cortes, Z. K. Liao, D. Watson and H. Kohn, J. Med. Chem.,
1985, 28, 601.
Sodium hydride (1.3 mmol) was added to a mixture of the
benzimidazolium iodide 6a,b (1.0 mmol) and elemental sulfur (8.0
mmol) in dry THF (30 mL) and stirred for 5 h at room temperature
under an argon atmosphere. After 5 h the solution was filtered, the
filtrate was concentrated under reduced pressure and purified by
flash chromatography using EtOAc/hexanes to afford pure
benzimidazole-thione 5a,b.
14 R. Sarges, R. C. Schnur, J. L. Belletire and M. J. Peterson, J. Med.
Chem., 1988, 31, 230.
15 A. R. Katritzky and A. F. Pozharskii, Handbook of Heterocyclic
Chemistry, 2nd edn, 2000.
16 A. F. Pozharskii, A. T. Soldatenkov and A. R. Katritzky,
Heterocycles in Life and Society: An Introduction to Heterocyclic
Chemistry, 1997.
(E)-1-butyl-3-((4-methoxybenzylidene)amino)-1H-benzo[d]i-
midazole-2(3H)-thione 5a. White solid (90%): m.p. 120–122 uC;
1H NMR (CDCl3): d 10.07 (s, 1H), 7.90 (d, J = 8.7 Hz, 2H), 7.50–7.46
(m, 1H), 7.27–7.18 (m, 3H), 6.99 (d, J = 8.7 Hz, 2H), 4.35 (t, J = 7.5
Hz, 2H), 1.89–1.79 (m, 2H), 1.53–1.41 (m, 2H), 0.99 (t, J = 7.4 Hz,
3H); 13C NMR (CDCl3): d 163.6, 162.4, 161.1, 131.5, 130.1, 129.8,
125.6, 123.2, 122.8, 114.1, 109.9, 108.5, 55.4, 44.1, 29.9, 20.2, 13.8;
Anal. Calcd. for C19H21N3OS: C, 67.23; H, 6.24; N, 12.38. Found: C,
67.26; H, 6.38; N, 12.33.
17 I. Shinkai, Five-Membered Rings with Two Heteroatoms and
Fused Carbocyclic Derivatives, Comprehensive Heterocyclic
Chemistry II, 1996, vol. 3.
18 M. C. Bellucci, T. Marcelli, L. Scaglioni and A. Volonterio, RSC
Adv., 2011, 1, 1250.
19 G. Herrmann and G. Suess-Fink, Synthesis, 1986, 422.
20 W. Kantlehner, Science of Synthesis, 2005, 22, 795.
21 H. Heitz, G. Herrmann and G. Suess-Fink, Chem. Ber., 1986,
119, 2895.
22 A. R. Katritzky, D. Jishkariani, R. Sakhuja, C. D. Hall and P.
J. Steel, J. Org. Chem., 2011, 76, 4082.
(E)-1-(benzylideneamino)-3-butyl-1H-benzo[d]imidazole-
2(3H)-thione 5b. Colorless crystals (88%): m.p. 106–108 uC, H
1
23 H. E. Winberg and D. D. Coffman, J. Am. Chem. Soc., 1965, 87,
2776.
24 Y. Cheng, M.-F. Liu, D.-C. Fang and X.-M. Lei, Chem.–Eur. J.,
2007, 13, 4282.
25 M. Regitz and J. Hocker, Synthesis, 1970, 301.
26 A. Sudo, K. Igarashi and T. Endo, J. Polym. Sci., Part A: Polym.
Chem., 2000, 38, 4200.
NMR (CDCl3): d 10.36 (s, 1H), 7.97–7.94 (m, 2H), 7.54–7.45 (m,
4H), 7.29–7.18 (m, 3H), 4.35 (t, J = 7.5 Hz, 2H), 1.89–1.79 (m, 2 H),
1.51–1.41 (m, 2H), 1.00 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3): d
163.8, 160.3, 133.3, 131.7, 130.0, 128.8, 128.5, 123.5, 123.0, 110.2,
108.7, 44.0, 29.8, 20.2, 13.9. Anal. Calcd. for C18H19N3S: C, 69.87;
H, 6.19; N, 13.58. Found: C, 69.98; H, 6.42; N, 13.43.
27 M. Regitz, J. Hocker, W. Schoessler, B. Weber and
A. Liedhegener, Justus Liebigs Ann. Chem., 1971, 748, 1.
28 B. R. Van Ausdall, J. L. Glass, K. M. Wiggins, A. M. Aarif and
J. Louie, J. Org. Chem., 2009, 74, 7935.
29 H. A. Duong, T. N. Tekavec, A. M. Arif and J. Louie, Chem.
Commun., 2004, 112.
References
1 E. A. Swinyard, J. A. Madsen and L. S. Goodman, J. Pharmacol.
Exp. Ther., 1954, 111, 54.
2 T. C. Butler and W. J. Waddell, J. Pharmacol. Exp. Ther., 1954,
110, 120.
30 A. M. Voutchkova, L. N. Appelhans, A. R. Chianese and R.
H. Crabtree, J. Am. Chem. Soc., 2005, 127, 17624.
31 H. Zhou, W.-Z. Zhang, C.-H. Liu, J.-P. Qu and X.-B. Lu, J. Org.
Chem., 2008, 73, 8039.
32 B. C. Norris, D. G. Sheppard, G. Henkelman and C.
W. Bielawski, J. Org. Chem., 2011, 76, 301.
3 D. Kim, L. Wang, C. G. Caldwell, P. Chen, P. E. Finke, B. Oates,
M. MacCoss, S. G. Mills, L. Malkowitz, S. L. Gould, J.
A. DeMartino, M. S. Springer, D. Hazuda, M. Miller,
J. Kessler, R. Danzeisen, G. Carver, A. Carella, K. Holmes,
J. Lineberger, W. A. Schleif and E. A. Emini, Bioorg. Med. Chem.
Lett., 2001, 11, 3099.
33 M. Hans, J. Wouters, A. Demonceau and L. Delaude, Eur. J. Org.
Chem., 2011, 7083.
msu.su.
4 D. Kim, L. Wang, C. G. Caldwell, P. Chen, P. E. Finke, B. Oates,
M. MacCoss, S. G. Mills, L. Malkowitz, S. L. Gould, J.
A. DeMartino, M. S. Springer, D. Hazuda, M. Miller,
J. Kessler, R. Danzeisen, G. Carver, A. Carella, K. Holmes,
1672 | RSC Adv., 2013, 3, 1669–1672
This journal is ß The Royal Society of Chemistry 2013